X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10074) 10074
Publication (1434) 1434
Book Review (111) 111
Book Chapter (60) 60
Newsletter (37) 37
Dissertation (35) 35
Conference Proceeding (20) 20
Magazine Article (15) 15
Web Resource (11) 11
Newspaper Article (3) 3
Trade Publication Article (3) 3
Book / eBook (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5242) 5242
index medicus (4614) 4614
microbiology (3937) 3937
infectious diseases (3240) 3240
carbapenems - pharmacology (3095) 3095
anti-bacterial agents - pharmacology (2934) 2934
microbial sensitivity tests (2727) 2727
carbapenems (2703) 2703
pharmacology & pharmacy (2691) 2691
male (1814) 1814
beta-lactamases - genetics (1678) 1678
female (1674) 1674
antibiotics (1607) 1607
bacteria (1440) 1440
carbapenem (1354) 1354
enterobacteriaceae (1327) 1327
middle aged (1298) 1298
anti-bacterial agents - therapeutic use (1292) 1292
carbapenem resistance (1281) 1281
infections (1247) 1247
drug resistance (1211) 1211
aged (1193) 1193
epidemiology (1170) 1170
beta-lactamases - metabolism (1141) 1141
carbapenems - therapeutic use (1102) 1102
escherichia-coli (1089) 1089
adult (1063) 1063
hospitals (1022) 1022
klebsiella-pneumoniae (1022) 1022
biochemical phenomena, metabolism, and nutrition (1021) 1021
drug resistance, bacterial (979) 979
bacterial proteins - genetics (944) 944
resistance (922) 922
beta-lactam resistance (905) 905
pseudomonas-aeruginosa (901) 901
acinetobacter baumannii - drug effects (887) 887
meropenem (880) 880
bacterial infections and mycoses (853) 853
polycyclic compounds (841) 841
drug resistance in microorganisms (833) 833
klebsiella pneumoniae - drug effects (825) 825
gram-negative bacteria (820) 820
acinetobacter baumannii (791) 791
pseudomonas aeruginosa - drug effects (772) 772
imipenem (761) 761
emergence (756) 756
antimicrobial resistance (729) 729
acinetobacter infections - microbiology (718) 718
drug resistance, multiple, bacterial (716) 716
cross infection - microbiology (707) 707
risk factors (703) 703
research (691) 691
mortality (681) 681
pseudomonas aeruginosa (679) 679
health aspects (676) 676
aged, 80 and over (671) 671
genes (671) 671
carbapenemase (662) 662
immunology (641) 641
pneumonia (636) 636
infectious disease (631) 631
enterobacteriaceae infections - microbiology (629) 629
klebsiella infections - microbiology (624) 624
enterobacteriaceae - drug effects (600) 600
antimicrobial agents (596) 596
bacterial proteins - metabolism (594) 594
klebsiella pneumoniae - isolation & purification (590) 590
animals (589) 589
polymerase chain reaction (577) 577
klebsiella pneumoniae (575) 575
outbreak (571) 571
nosocomial infections (563) 563
prevalence (561) 561
retrospective studies (547) 547
analysis (545) 545
acinetobacter baumannii - isolation & purification (539) 539
acinetobacter baumannii - genetics (535) 535
colistin (527) 527
infection (521) 521
klebsiella pneumoniae - genetics (514) 514
antibiotic resistance (512) 512
carbapenem-resistant enterobacteriaceae (512) 512
risk-factors (510) 510
thienamycins - pharmacology (504) 504
metallo-beta-lactamase (498) 498
beta-lactamases - biosynthesis (495) 495
bacteremia (493) 493
imipenem - pharmacology (481) 481
beta-lactamases (478) 478
molecular epidemiology (478) 478
cross infection - epidemiology (474) 474
identification (467) 467
surveillance (467) 467
intensive care units (465) 465
beta-lactamase (460) 460
susceptibility (457) 457
adolescent (456) 456
strains (456) 456
klebsiella pneumoniae - enzymology (454) 454
plasmids (452) 452
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9515) 9515
Japanese (205) 205
Spanish (136) 136
Chinese (81) 81
French (66) 66
Turkish (44) 44
Russian (35) 35
German (34) 34
Korean (24) 24
Polish (22) 22
Portuguese (17) 17
Czech (11) 11
Romanian (11) 11
Croatian (7) 7
Dutch (7) 7
Persian (5) 5
Italian (3) 3
Norwegian (3) 3
Danish (2) 2
Slovak (2) 2
Swedish (2) 2
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FEMS Microbiology Letters, ISSN 0378-1097, 08/2010, Volume 309, Issue 1, pp. 62 - 70
AbstractResistance to carbapenems in enterobacteria is mediated by the production of several types of carbapenemases or by the decreased permeability of the... 
Carbapenems
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 10/2010, Volume 36, Issue 4, pp. 343 - 347
Enterobacteriaceae other than Escherichia spp. and Klebsiella spp. are recognisable for their increasing resistance. Plasmid-mediated b-lactamases, including... 
Carbapenems
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 09/2010, Volume 36, Issue 3, pp. 259 - 263
Acquired metallo-b-lactamase (MBL) production is an important mechanism of carbapenem resistance. To our knowledge, carriage of two different MBLs has not been... 
Carbapenems
Journal Article
by Liu, Y and Yu, J and Fei, Q-L and Shen, L-S
Journal of Shanghai Jiaotong University (Medical Science)/Shanghai Jiaotong Daxue Xuebao (Yixue Ban), ISSN 1674-8115, 03/2013, Volume 33, Issue 3, pp. 275 - 279
Objective To investigate the resistance mechanism of Enterobacter aerogenes to carbapenems. Methods Sixteen isolates of carbapenem-resistant Enterobacter... 
Carbapenems
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 02/2018, Volume 51, Issue 2, pp. 244 - 248
Journal Article
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 11/2018, Volume 56, Issue 11
The rapid spread of multidrug-resistant Gram-negative organisms constitutes one of the greatest challenges to global health. While Gram-negative organisms have... 
Modified Hodge test | Carba NP test | Carbapenemase-producing Enterobacteriaceae | Carbapenemase-producing organism | Carbapenemase | Lateral flow assay | Carba NP | Lateral flow antigen | Modified carbapenem inactivation method | Phenotypic | KLEBSIELLA-PNEUMONIAE CARBAPENEMASE | lateral flow assay | ANTIBIOTIC-RESISTANCE MECHANISMS | modified Hodge test | MICROBIOLOGY | METALLO-BETA-LACTAMASES | IMMUNOCHROMATOGRAPHIC TEST | carbapenemase | carbapenemase-producing Enterobacteriaceae | modified carbapenem inactivation method | carbapenemase-producing organism | phenotypic | lateral flow antigen | K-SET ASSAY | FLIGHT MASS-SPECTROMETRY | DESORPTION IONIZATION-TIME | RAPID DETECTION | Carbapenems - metabolism | Immunoassay | Carbapenem-Resistant Enterobacteriaceae - isolation & purification | beta-Lactamases - immunology | Bacteriological Techniques - methods | Enterobacteriaceae Infections - microbiology | Humans | Anti-Bacterial Agents - metabolism | Bacterial Proteins - analysis | Microbial Sensitivity Tests | Carbapenem-Resistant Enterobacteriaceae - enzymology | Carbapenems - pharmacology | beta-Lactamases - classification | beta-Lactamases - analysis | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - classification | Bacterial Proteins - immunology | beta-Lactamases - metabolism | Carbapenem-Resistant Enterobacteriaceae - drug effects | beta-Lactam Resistance - drug effects
Journal Article
Drug Resistance Updates, ISSN 1368-7646, 2016, Volume 29, pp. 30 - 46
Abstract Carbapenems, our one-time silver bullet for multidrug resistant bacterial infections, are now threatened by widespread dissemination of... 
Infectious Disease | Hematology, Oncology and Palliative Medicine | Carbapenem Resistant Enterobacteriaceae | Antibiotic resistance | Horizontal gene transfer | NDM-PRODUCING ENTEROBACTERIACEAE | CLASS-A CARBAPENEMASE | MODIFIED HODGE TEST | ESCHERICHIA-COLI | METALLO-BETA-LACTAMASE | NEW-YORK-CITY | PHARMACOLOGY & PHARMACY | INCFII-TYPE PLASMIDS | RIBOSOMAL-RNA METHYLASE | IN-VITRO ACTIVITY | KLEBSIELLA-PNEUMONIAE INFECTION | Humans | Isoenzymes - classification | Enterobacteriaceae Infections - epidemiology | Carbapenem-Resistant Enterobacteriaceae - enzymology | Carbapenem-Resistant Enterobacteriaceae - genetics | Carbapenems - pharmacology | beta-Lactamases - genetics | Isoenzymes - metabolism | Enterobacteriaceae Infections - transmission | beta-Lactamases - metabolism | Drug Therapy, Combination | Gene Expression | Isoenzymes - genetics | Enterobacteriaceae Infections - microbiology | Bacterial Proteins - genetics | beta-Lactamase Inhibitors - pharmacology | Plasmids - metabolism | beta-Lactamases - classification | Epidemiological Monitoring | Carbapenem-Resistant Enterobacteriaceae - pathogenicity | Plasmids - chemistry | Bacterial Proteins - metabolism | Bacterial Proteins - classification | beta-Lactam Resistance - genetics | Drug Resistance, Multiple, Bacterial - genetics | Carbapenem-Resistant Enterobacteriaceae - drug effects | Enterobacteriaceae Infections - drug therapy | Replicon | Medical colleges | Drug resistance in microorganisms | Bacterial infections | Mortality | Genomics | Beta lactamases | Nucleotide sequencing | Chromosomes | Antibacterial agents | Biomedical engineering | DNA sequencing | Anopheles | Genes
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE... 
acute pyelonephritis | ceftazidime-avibactam | complicated urinary tract infection | INFECTIOUS DISEASES | INITIAL ANTIBIOTIC-THERAPY | ANTIMICROBIAL THERAPY | MICROBIOLOGY | IMMUNOLOGY | INTRAABDOMINAL INFECTION | CARBAPENEM-RESISTANT ENTEROBACTERIACEAE | TREATMENT OPTIONS | BACTERICIDAL ACTIVITY | PSEUDOMONAS-AERUGINOSA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | KLEBSIELLA-PNEUMONIAE | Doripenem | Azabicyclo Compounds - administration & dosage | Carbapenems - administration & dosage | Humans | Middle Aged | Male | Pyelonephritis - complications | Urinary Tract Infections - complications | Urinary Tract Infections - drug therapy | Carbapenems - adverse effects | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Ceftazidime - administration & dosage | Adult | Azabicyclo Compounds - therapeutic use | Female | Aged | Anti-Bacterial Agents - adverse effects | Ceftazidime - adverse effects | Pyelonephritis - drug therapy | Anti-Bacterial Agents - administration & dosage | Ceftazidime - therapeutic use | Drug Combinations | Azabicyclo Compounds - adverse effects | Care and treatment | Usage | Pyelonephritis | Clinical trials | Urinary tract infections | Influence | Dosage and administration | Ceftazidime | Antibiotics | Drug resistance | Drug therapy | CRE bacteria | Urinary tract diseases | and Commentaries
Journal Article
Brief Communication - INCIDENCE OF CARBAPENEM RESISTANT NONFERMENTING GRAM NEGATIVE BACILLI FROM PATIENTS WITH RESPIRATORY INFECTIONS IN THE INTENSIVE CARE UNITS, 12/2005
Resistance to carbapenems is commonly seen in nonfermenting gram negative bacilli (NFGNB). We document herein the prevalence of carbapenem resistance in NFGNB... 
Carbapenem resistance, NFGNB, ICUs
Journal
Future Microbiology, ISSN 1746-0913, 08/2017, Volume 12, Issue 10, pp. 891 - 904
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue suppl_2, pp. S68 - S75
Background. Since 2010, the incidence of carbapenem-resistant Enterobacteriaceae (CRE) has been increasing in Singapore. We analyzed the clinical and molecular... 
Carbapenem-resistant Enterobacteriaceae | Antimicrobial resistance | Whole-genome sequencing | Epidemiology | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RISK-FACTORS | whole-genome sequencing | ACQUISITION | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | IMMUNOLOGY | carbapenem-resistant Enterobacteriaceae | epidemiology | antimicrobial resistance | BETA-LACTAMASE | SPREAD | KLEBSIELLA-PNEUMONIAE INFECTION | Klebsiella pneumoniae - isolation & purification | beta-Lactam Resistance | Carbapenem-Resistant Enterobacteriaceae - isolation & purification | Humans | Male | beta-Lactamases - biosynthesis | Incidence | Young Adult | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Inpatients | Klebsiella Infections - epidemiology | Carbapenem-Resistant Enterobacteriaceae - genetics | Carbapenems - pharmacology | beta-Lactamases - genetics | Enterobacteriaceae Infections - transmission | Klebsiella pneumoniae - genetics | Adult | Female | Surveys and Questionnaires | Cross Infection - epidemiology | Enterobacter cloacae - genetics | Genome, Bacterial | Enterobacteriaceae Infections - microbiology | Escherichia coli Infections - epidemiology | DNA, Bacterial - genetics | Carbapenems - therapeutic use | Escherichia coli - genetics | Escherichia coli - isolation & purification | Aged | Enterobacter cloacae - isolation & purification | High-Throughput Nucleotide Sequencing | Carbapenem-Resistant Enterobacteriaceae - drug effects | Electronic Health Records | Klebsiella | Enterobacter cloacae | Carbapenemase | Genomes | Multivariate analysis | Electronic medical records | Gene sequencing | Disease transmission | Hospitals | E coli | Plasmids | Medical electronics | Clusters | Bacteria | Electronic health records | Public health | Indexing
Journal Article
Journal Article